Tevimbra (Tislelizumab-jsgr) Injection

Tevimbra (tislelizumab-jsgr), from BeiGene, is indicated for the treatment of unresectable or metastatic esophageal squamous cell carcinoma after prior chemotherapy, and other advanced solid tumor indications depending on region-specific approvals.

Tislelizumab-jsgr is a PD-1 immune checkpoint inhibitor that blocks the interaction between PD-1 and its ligands, restoring T-cell-mediated immune responses against tumor cells.

• Immune-mediated adverse reactions can affect any organ system, including pneumonitis, colitis, hepatitis, endocrinopathies, and nephritis — monitor closely throughout treatment.
• Infusion-related reactions may occur.
• Embryo-fetal toxicity — can cause fetal harm; effective contraception is advised.
• Requires administration by a healthcare professional prepared to manage immune-related reactions.

What documents are required to import Tevimbra to India?

Tevimbra may be imported in the patient’s name only, by patients or government hospitals. The following documentation is required:

• A valid prescription from a registered oncologist
• Diagnostic/pathology report confirming the applicable cancer diagnosis
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription.

Is Tevimbra available in India?

Tevimbra is not commercially marketed in India. It can be legally accessed through the Named Patient Program (NPP).

Indian Pharma Network (IPN) can source Tevimbra from its authorized distribution network and facilitate supply to patients, doctors, and hospitals under applicable legal provisions.

For Tevimbra cost in India and availability, contact IPN at Phone: +91-9310090915 or email info@indianpharmanetwork.in.

Global Approval Status:

• United States: Approved by the FDA — March 2024 (esophageal squamous cell carcinoma).

What is Tevimbra used for?

Tevimbra treats unresectable or metastatic esophageal squamous cell carcinoma after prior chemotherapy.

Who manufactures Tevimbra?

Tevimbra is developed by BeiGene.

How is Tevimbra administered?

By intravenous infusion, dosed per the treating oncologist’s protocol.

How much does Tevimbra cost in India?

Cost depends on treatment cycles and sourcing logistics — share your prescription with IPN for a quote.